Testosterone replacement in prostate cancer survivors with hypogonadal symptoms
Monday, December 7th, 2009 Posted in hormone therapy | No Comments »There controversy over the role of testosterone replacement therapy (TRT) in men with prostate cancer who are “hypogonadal” continues — i.e., men with very low testosterone levels — as a consequence of their treatment. A new study at University of Southern California, ...
The possible link between obesity and prostate cancer risk
Sunday, December 6th, 2009 Posted in prostate cancer risks | No Comments »A 25-year-long prospective study at Brigham and Women's Hospital and Harvard Medical School, Boston, has shown that relatively higher prediagnostic serum levels of a naturally occurring chemical called adiponectin in man seems to predispose men to a lower risk of ...
Living with a prostate cancer diagnosis
Saturday, December 5th, 2009 Posted in prostate cancer diagnosis | No Comments »Urologists agree there is need for knowledge and guidance for men with prostate cancer on how to adapt to new life situation decreasing uncertainty and increasing welfare Previous research has identified how newly diagnosed prostate cancer affects men's daily lives, including ...
quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy
Friday, December 4th, 2009 Posted in prostatectomy, radiation therapy | No Comments »A new study at University of Toronto, Ontario, Canada, aims to examine and compare changes in quality of life after two common treatments for prostate cancer (PC), radical prostatectomy (RP) and radiation therapy (RT). Patients newly diagnosed with localized PC, ...
Saturation biopsies for prostate cancer
Thursday, December 3rd, 2009 Posted in prostate cancer | No Comments »Since its introduction, ultrasound-guided prostate biopsy has undergone significant evolution. Because of the low sensitivity of ultrasonography in detecting prostate cancer, tissue is sampled randomly within the gland. In an attempt to enhance cancer detection and characterization, the trend has ...
PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients
Wednesday, December 2nd, 2009 Posted in prostate cancer | No Comments »According to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO), prostate cancer patients who have a prostate-specific antigen (PSA) value of less than ...
Statin use might be associated with prostate cancer aggressiveness
Tuesday, December 1st, 2009 Posted in prostate cancer | No Comments »Two studies at Johns Hopkins School of Medicine and Northwestern Feinberg School of Medicine, Chicago, aimed to examine the association between statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) and pathological features in a large group of patients undergoing radical prostatectomy (RP). ...